Accurate. Non-Invasive. Clinically Actionable.
The BRAF PCR Test provides veterinarians with a powerful molecular tool for detecting canine urothelial carcinoma using a simple urine sample. By identifying the BRAF V595E mutation, this test supports earlier diagnostic clarity while reducing the need for invasive procedures.
Ideal for dogs presenting with persistent lower urinary tract signs, the BRAF PCR Test helps differentiate malignant disease from inflammatory conditions and supports confident clinical decision-making. Rapid turnaround times and clear reporting make it a reliable option for both initial diagnosis and ongoing disease monitoring.
Key Benefits
With up to 85% of canine bladder tumors carrying the BRAF V595E mutation, molecular testing plays a critical role in diagnostic confidence. The BRAF PCR Test delivers accurate, non-invasive detection from a simple urine sample—helping veterinarians reach clearer answers sooner.
Designed to support early confirmation, treatment planning, and ongoing monitoring, this test offers reliable results without invasive procedures. It’s a powerful diagnostic advantage for practices managing challenging urinary tract cases..
Certain breeds face a significantly higher risk of developing canine bladder cancer, making early molecular screening especially valuable. Terriers and other predisposed breeds often present with urinary signs that can mimic inflammatory disease, delaying definitive diagnosis.
The BRAF PCR Test provides a non-invasive way to move from risk awareness to diagnostic clarity. By identifying a highly prevalent mutation associated with urothelial carcinoma, this test helps veterinarians act earlier, monitor more effectively, and reduce uncertainty in high-risk patients.
Ideal for:
When bladder cancer is a concern, early action makes the difference. The BRAF PCR Test allows veterinarians to screen at-risk patients using a simple urine sample and quickly identify a cancer-associated mutation.
By integrating seamlessly into everyday workflows, this test helps confirm suspicion, guide next steps, and support timely treatment decisions—without invasive diagnostics. Screen sooner, act confidently, and monitor effectively.
Take action when it matters most:
Identify at-risk patients
Collect a urine sample
Order the BRAF PCR Test
Get clear, actionable results
